

Ulta Beauty Leaps, Cooper Companies Slump, Regeneron Plunges on Disappointing Data
May 30, 2025
Ulta Beauty's shares soared by 16% after its positive earnings forecast, indicating strong performance despite competition. In contrast, Cooper Companies saw a slump due to lowered growth outlook, even with better-than-expected quarterly results. Regeneron Pharmaceuticals faced a sharp decline after its COPD treatment failed in a Phase 3 study, leading to a downgrade by Wells Fargo. This discussion highlights the stark differences in stock performances across industries amidst changing economic conditions.
AI Snips
Chapters
Transcript
Episode notes
Ulta Beauty's Market Surge
- Ulta Beauty shares surged about 15% due to a boosted earnings forecast and easing competitive pressures from new distribution points like Sephora.
- Analysts note strong execution at Ulta and abating competition increases investor confidence.
Beauty as Recession-Proof
- The "lipstick index" suggests beauty product sales often stay strong during economic uncertainty as consumers seek comfort.
- Beauty is sometimes seen as recession-proof since people often keep purchasing despite macroeconomic challenges.
Impact of Outlook on Cooper Shares
- Cooper Companies shares dropped 12% after cutting its organic growth outlook despite better-than-expected quarterly results.
- The lowered guidance led to a JPMorgan downgrade and highlights the importance of outlook on stock performance.